MedTrace Logo

Replacing Bone Marrow Diagnostics With Peripheral Blood Analysis in MPN Patients

NCT07648433 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2026-09-01

No results posted yet for this study

Summary

The PERIBLOOD-MPN study aims to develop and validate a minimally invasive peripheral blood test using single-cell RNA sequencing to accurately diagnose and classify myeloproliferative neoplasms, potentially reducing the need for invasive bone marrow biopsies.

Conditions

  • Myeloproliferative Neoplasm

Interventions

DIAGNOSTIC_TEST

PERIBLOOD-MPN

Observational intervation of cHSPCs

Sponsors & Collaborators

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-10-31
Primary Completion
2029-06-30
Completion
2032-06-30
FDA Device
Yes

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07648433 on ClinicalTrials.gov